Navigation Links
New Agreements and Stock Movements in Healthcare Companies - Research Report on Abbott, Thermo Fisher, Intuitive Surgical, Mindray, and Zeltiq
Date:11/27/2013

NEW YORK, November 27, 2013 /PRNewswire/ --

Editor Note: For more information about this release, please scroll to bottom.

Today, Analysts' Corner announced new research reports highlighting Abbott Laboratories (NYSE: ABT),

Thermo Fisher Scientific Inc. (NYSE: TMO), Intuitive Surgical, Inc. (NASDAQ: ISRG), Mindray Medical International Ltd (NYSE: MR), and Zeltiq Aesthetics Inc. (NASDAQ: ZLTQ). Today's readers may access these reports free of charge - including full price targets, industry analysis and analyst ratings - via the links below.

Abbott Laboratories Research Report

On November 22, 2013, stocks of Abbott Laboratories (Abbott) rose 0.47% to $38.25 at the end of trading. Over the previous three trading sessions, Abbott's shares slipped by 1.19% when compared to the Dow Jones Industrial Average which rose 0.61% during the same period. The Full Research Report on Abbott Laboratories - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/05c1_ABT

--

Thermo Fisher Scientific Inc. Research Report

On November 21, 2013, Reuters reported that Thermo Fisher Scientific Inc. (Thermo Fisher) and OraSureTehcnologies Inc. have entered into a new agreement. Reuters informed that the said agreement is for the development and distribution of fully automated oral fluid drugs of abuse assays, in which a NIDA-5 panel of assay is expected to be initially sold starting in H2 2014. The Full Research Report on Thermo Fisher Scientific Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/45ed_TMO

--

Intuitive Surgical, Inc. Research Report

On November 22, 2013, stocks of Intuitive Surgical, Inc. (Intuitive Surgical) slipped 0.21% to $389.71 at the end of trading. Shares of Intuitive Surgical dropped 1.23% over the past three trading sessions, while the Nasdaq composite rose 1.53% during the same period. The Full Research Report on Intuitive Surgical, Inc. - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/5f98_ISRG

--

Mindray Medical International Ltd Research Report

On November 22, 2013, Mindray Medical International Ltd's (Mindray) shares ended at $39.45, indicating a 1.55% drop. Over the past three trading sessions, shares of Mindray went up 2.07% while the Dow Jones Industrial Average also rose 0.61% during thE same period. The Full Research Report on Mindray Medical International Ltd - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/8d4d_MR

--

Zeltiq Aesthetics Inc Research Report

On November 22, 2013, shares of Zeltiq Aesthetics Inc (Zeltiq) rose 6.91% to $16.71 at the end of trading. Over the past three trading sessions, shares of Zeltiq soared 11.47% while the Nasdaq composite also rose 1.53% during thE same period. The Full Research Report on Zeltiq Aesthetics Inc - including full detailed breakdown, analyst ratings and price targets - is available to download free of charge at:

http://www.analystscorner.com/r/full_research_report/b15b_ZLTQ

----

EDITOR NOTES:

  1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.
  2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Ananya Ghosh, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.
  3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.
  4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco@EquityNewsNetwork.com.
  5. For any urgent concerns or inquiries, please contact us at compliance@EquityNewsNetwork.com.
  6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research@EquityNewsNetwork.com for consideration.

COMPLIANCE PROCEDURE

Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Equity News Network. An outsourced research services provider represented by Ananya Ghosh, CFA, has only reviewed the information provided by Equity News Network in this article or report according to the Procedures outlined by Equity News Network. Equity News Network is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE

Equity News Network makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED

Equity News Network is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Equity News Network whatsoever for any direct, indirect or consequential loss arising from the use of this document. Equity News Network expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Equity News Network does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

http://AnalystsCorner.com

 


'/>"/>
SOURCE Analysts' Corner
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Discovery, Preclinical and Clinical Stage Partnering Terms and Agreements in Pharma and Biotech
2. Financial Results, Agreements, Meetings, and Clinical Trials - Research Report on Cell Therapeutics, Akorn, Ligand, Intercept Pharmaceuticals and Ariad Pharmaceuticals
3. Sequenom Announces License And Marketing Agreements With Laboratoire Cerba In France
4. NxStage Announces New Agreements with DaVita
5. Cancer Vaccine Partnering Terms and Agreements
6. Allergans Global Dominance in Facial Injectables Challenged by Acquisitions and Partnership Agreements Among Competitors
7. Novation Awards Cardiovascular Agreements
8. Lifecycle Management Strategies: Pharma-Payer Deals - Creative agreements are used at different stages of the brand lifecycle to maximize sales
9. Sequenom Completes International Distribution Agreements To Expand Access To MaterniT21 PLUS Prenatal Testing Service
10. BioDrain Medical Inc. Signs Additional Independent Distribution Agreements, Strengthening Nationwide Presence
11. Vaccine Partnering Terms and Agreements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... 2016 According to the 2016 ... driving ambulatory blood pressure monitoring system market growth. With ... ability to respond to different pressure rates, leading to ... to various cardiovascular disorders such as heart failure, stroke, ... are growing in prevalence each year. WHO estimates that ...
(Date:5/26/2016)... May 26, 2016 According to a ... Management Market - U.S. Industry Analysis, Size, Share, Growth, Trends, ... in the U.S. was valued at US$ 5.89 Bn in ... 3.4% from 2015 to 2023 to reach US$ 7.99 Bn ... current and emerging needle free drug delivery devices and the ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology:
(Date:5/31/2016)... (PRWEB) , ... May 31, 2016 , ... In a ... Paul Feiner and broadcast on New Rochelle, NY-based WVOX (1460 AM), leading ... create what she calls the country’s “modern medical money maelstrom.” , During the ...
(Date:5/31/2016)... ... May 31, 2016 , ... Advertising Age has recognized ... provider, for the tenth consecutive year as a Top 20 Marketing Services Agency. ... SourceLink ranked eighteenth in the “U.S. CRM/Direct Marketing Agency” category. , Recent ...
(Date:5/31/2016)... Port Washington, NY (PRWEB) , ... May 31, 2016 , ... ... and other essential nutrients to on the go individuals and dedicated athletes, continues to ... functions. , Loaded with whey, pea and milk protein, branched-chain amino acids (BCAA), ...
(Date:5/30/2016)... (PRWEB) , ... May 30, 2016 , ... ... small businesses, announced today the publication of an original infographic, " Health Benefits ... health insurance professionals understand how Zane Benefits complies with various federal regulations and ...
(Date:5/29/2016)... ... May 29, 2016 , ... Whole Health Supply is happy ... that has been available via Amazon.com. This new style of nail clipper has a ... jaw opening is approximately 4mm and the actual handle is 2.5mm thick to accommodate ...
Breaking Medicine News(10 mins):